Evofem Biosciences Stock Filter Stocks by Fundamentals
EVFMDelisted Stock | USD 0.05 0.0001 0.21% |
Evofem Biosciences fundamentals help investors to digest information that contributes to Evofem Biosciences' financial success or failures. It also enables traders to predict the movement of Evofem OTC Stock. The fundamental analysis module provides a way to measure Evofem Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evofem Biosciences otc stock.
Evofem |
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Evofem Fundamentals
Return On Equity | -3.87 | ||||
Return On Asset | -1.25 | ||||
Operating Margin | (5.41) % | ||||
Current Valuation | 112.69 M | ||||
Shares Outstanding | 121.22 M | ||||
Shares Owned By Insiders | 0.28 % | ||||
Shares Owned By Institutions | 0.57 % | ||||
Number Of Shares Shorted | 8.68 M | ||||
Price To Earning | (1.26) X | ||||
Price To Book | 8.37 X | ||||
Price To Sales | 0.42 X | ||||
Revenue | 8.24 M | ||||
Gross Profit | 4.19 M | ||||
EBITDA | (204.14 M) | ||||
Net Income | (205.19 M) | ||||
Cash And Equivalents | 19.89 M | ||||
Cash Per Share | 0.23 X | ||||
Total Debt | 125.74 M | ||||
Debt To Equity | 8.72 % | ||||
Current Ratio | 0.16 X | ||||
Book Value Per Share | (0.77) X | ||||
Cash Flow From Operations | (146.67 M) | ||||
Short Ratio | 0.19 X | ||||
Earnings Per Share | (19.01) X | ||||
Target Price | 2.9 | ||||
Number Of Employees | 119 | ||||
Beta | -1.25 | ||||
Market Capitalization | 6.41 M | ||||
Total Asset | 42.51 M | ||||
Retained Earnings | (526.68 M) | ||||
Working Capital | 3.78 M | ||||
Current Asset | 16.39 M | ||||
Current Liabilities | 12.61 M | ||||
Z Score | -30.0 | ||||
Net Asset | 42.51 M |
About Evofem Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evofem Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evofem Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evofem Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Evofem Biosciences information on this page should be used as a complementary analysis to other Evofem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Evofem OTC Stock
If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |